TECH OUTLOOK 6AUGUST - 2021TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comA new wave of technologies is entering the pharma industry in 2021, urging organizations to upgrade their digital capabilities and keep up with the break-neck competition in the market. Especially with the COVID-19 pandemic tipping the world into a volatile new phase, it is becoming all the more imperative for pharma organizations to reinvent many of their processes according to the changing consumer behavior. However, data by itself is of no use unless valuable insights are derived from it. This is why data analytics is currently becoming the need of the hour for pharma companies. In fact, data analytics is expected to help organizations in improving the standard of care based on patients' demographics and historical data, their preferences, etc. Data analytics can also help in streamlining clinical trials and reducing the associated costs by analyzing available data on drug candidates from both clinical and academic studies. Considering all these trends, it is paramount for foresighted organizations to invest in robust data analytics services able to further their goals.When all is said and done, keeping up with the latest analytics trends and maintaining a competitive edge will require expert guidance. Pharma institutions must respond accordingly by forging partnerships with the best analytical services companies in the world. In this edition of Pharma Tech Outlook, we bring to you the story of some of the most successful analytical services companies that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the best analytical services companies according to your requirements.Let us know your thoughts!Data Analytics-Led Pharma InnovationCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.AUGUST - 23 - 2021, Vol 07 - Issue 06 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerDavid ParkerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405TECH OUTLOOK
< Page 5 | Page 7 >